JPRN-C000000423已完成未知
Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantation - Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD
Jichi Medical University, Department of Medicine, Division of Hematology0 个研究点目标入组 5 人开始时间: 2006年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) in relapse disease status 2) in unconsciousness 3) in severe infection
研究者
相似试验
进行中（未招募）
1 期
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeModerate to severe SARS-Cov-2 related acute respiratory distress syndromeMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2020-002772-12-FRCHRU NANCY30
进行中（未招募）
不适用
Mesenchymal stem cell based therapy for the treatment of osteogenesis imperfectaOsteogenesis imperfecta (OI) is a rare genetic disorder with increased bone fragility of varying severity. In the majority of patients the disease is caused by mutations in collagen type I. Severe OI is characterized by osteopenia, frequent fractures, progressive deformity, short stature, loss of mobility, chronic pain and can lead to premature death. At present a cure does not exist.EUCTR2012-002553-38-ESItziar Astigarraga Aguirre
招募中
1 期
Evaluation the efficacy of stem cells condition medium on hair transplantation outcomeHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N18Skin and Stem cell Research Center of Tehran University of Medical Sciences30
已完成
不适用
Effects of cell therapy with mesenchymal stem cells and platelet-rich plasma in the treatment of knee osteoarthritisOsteoarthritis, KneeRBR-2fr526nniversidade Federal de Mato Grosso do Sul
撤回
不适用
Application of mesenchymal stem cells in patients with end-stage renal diseaseNL-OMON34665Erasmus MC, Universitair Medisch Centrum Rotterdam16